« previous next »
Pages: [1]

Author Topic: (Abst.) Effect of switching from Tysabri to moderate- vs. high-efficacy DMT in clinical practice  (Read 92 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Effect of switching from Tysabri to moderate- vs. high-efficacy DMT in clinical practice
« on: February 24, 2020, 07:52:32 pm »

From Neurology Clinical Practice (February 12, 2020), "Effect of switching from natalizumab to moderate- vs. high-efficacy DMT  in clinical practice"

https://cp.neurology.org/content/early/2020/02/12/CPJ.0000000000000809
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Natalizumab switch to moderate-efficacy DMT increases disability risk
« Reply #1 on: May 29, 2020, 09:45:07 pm »
More on this from Medscape (May 27, 2020)--"Natalizumab switch to moderate-efficacy DMT  increases disability risk":


https://www.medscape.com/viewarticle/931195




Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
79 Views 		Last post April 17, 2019, 02:42:04 pm
by agate
0 Replies
101 Views 		Last post May 11, 2019, 02:32:11 pm
by agate
0 Replies
95 Views 		Last post May 11, 2019, 03:15:44 pm
by agate
0 Replies
24 Views 		Last post May 24, 2022, 09:39:45 pm
by agate
0 Replies
10 Views 		Last post March 30, 2024, 10:08:37 pm
by agate